CoChat
Sign Up
Cited by 40

The DOI matches its Crossref record.

Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy

Liebregts, Max, Vriesendorp, Pieter A., ten Berg, Jurrien M.·2017·Journal of the American College of Cardiology
DOI 10.1016/j.jacc.2017.02.080
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2017.02.080

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 40

  1. Maron, 1995, Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA study, Circulation, 92, 785, 10.1161/01.CIR.92.4.785 · DOI
  2. Maron, 2006, Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction, Circulation, 114, 2232, 10.1161/CIRCULATIONAHA.106.644682 · DOI
  3. Gersh, 2011, 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, J Am Coll Cardiol, 58, 2703, 10.1016/j.jacc.2011.10.825 · DOI
  4. Elliott, 2014, 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC), Eur Heart J, 35, 2733, 10.1093/eurheartj/ehu284 · DOI · Paper page
  5. Maron, 1987, Hypertrophic cardiomyopathy: interrelations of clinical manifestations, pathophysiology, and therapy, N Engl J Med, 316, 844, 10.1056/NEJM198704023161405 · DOI
  6. Goodwin, 1960, Obstructive cardiomyopathy simulating aortic stenosis, Br Heart J, 22, 403, 10.1136/hrt.22.3.403 · DOI
  7. Morrow, 1975, Operative treatment in hypertrophic subaortic stenosis: technique, and the results of pre and postoperative assessments in 83 patients, Circulation, 52, 88, 10.1161/01.CIR.52.1.88 · DOI
  8. Sherrid, 2016, The mitral valve in obstructive hypertrophic cardiomyopathy: a test in context, J Am Coll Cardiol, 67, 1846, 10.1016/j.jacc.2016.01.071 · DOI
  9. Vriesendorp, 2015, Long-term benefit of myectomy and anterior mitral leaflet extension in obstructive hypertrophic cardiomyopathy, Am J Cardiol, 115, 670, 10.1016/j.amjcard.2014.12.017 · DOI
  10. Brugada, 1989, Transcoronary chemical ablation of ventricular tachycardia, Circulation, 79, 475, 10.1161/01.CIR.79.3.475 · DOI
  11. Gietzen, 1994, Abnahme der Obstruktion bei hypertrophischer Kardiomyopathie während passagerer Okklusion des ersten Septalastes der linken Koronararterie, Z Kardiol, 83, 146
  12. Sigward, 1995, Non-surgical myocardial reduction of hypertrophic obstructive cardiomyopathy, Lancet, 346, 211, 10.1016/S0140-6736(95)91267-3 · DOI
  13. Olivotto, 2007, Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy: will there ever be a randomised trial?, J Am Coll Cardiol, 50, 831, 10.1016/j.jacc.2007.05.018 · DOI
  14. Agarwal, 2010, Updated meta-analysis of septal alcohol ablation versus myectomy for hypertrophic cardiomyopathy, J Am Coll Cardiol, 55, 823, 10.1016/j.jacc.2009.09.047 · DOI
  15. Liebregts, 2015, A systematic review and meta-analysis of long-term outcomes after septal reduction therapy in patients with hypertrophic cardiomyopathy, J Am Coll Cardiol HF, 3, 896
  16. ten Cate, 2010, Long-term outcome of alcohol septal ablation in patients with obstructive hypertrophic cardiomyopathy: a word of caution, Circ Heart Fail, 3, 362, 10.1161/CIRCHEARTFAILURE.109.862359 · DOI
  17. Sorajja, 2012, Survival after alcohol septal ablation for obstructive hypertrophic cardiomyopathy, Circulation, 126, 2374, 10.1161/CIRCULATIONAHA.111.076257 · DOI
  18. Steggerda, 2014, Periprocedural complications and long-term outcome after alcohol septal ablation versus surgical myectomy in hypertrophic obstructive cardiomyopathy: a single-center experience, J Am Coll Cardiol Intv, 7, 1227, 10.1016/j.jcin.2014.05.023 · DOI
  19. Vriesendorp, 2014, Long-term outcomes after medical and invasive treatment in patients with hypertrophic cardiomyopathy, J Am Coll Cardiol HF, 2, 630
  20. Samardhi, 2014, The long-term outcomes of transcoronary ablation of septal hypertrophy compared to surgical myectomy in patients with symptomatic hypertrophic obstructive cardiomyopathy, Catheter Cardiovasc Interv, 83, 270, 10.1002/ccd.25134 · DOI
  21. Sedehi, 2015, Long-term outcomes of septal reduction for obstructive hypertrophic cardiomyopathy, J Cardiol, 66, 57
  22. Yang, 2015, Survival after alcohol septal ablation versus conservative therapy in obstructive hypertrophic cardiomyopathy, Cardiol J, 22, 657, 10.5603/CJ.a2015.0032 · DOI
  23. Lyne, 2010, Long-term follow-up of the first patients to undergo transcatheter alcohol septal ablation, Cardiology, 116, 168, 10.1159/000318307 · DOI
  24. Veselka, 2014, Long-term survival after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a comparison with general population, Eur Heart J, 35, 2040, 10.1093/eurheartj/eht495 · DOI
  25. Kim, 2016, Hospital volume outcomes after septal myectomy and alcohol septal ablation for treatment of obstructive hypertrophic cardiomyopathy: US Nationwide Inpatient Database, 2003–2011, JAMA Cardiol, 1, 324, 10.1001/jamacardio.2016.0252 · DOI
  26. Maron, 2011, Controversies in cardiovascular medicine. Benefits of surgery in obstructive hypertrophic cardiomyopathy: bring myectomy back for European patients, Eur Heart J, 32, 1055, 10.1093/eurheartj/ehr006 · DOI
  27. Bonow, 2008, J Am Coll Cardiol, 52, e1, 10.1016/j.jacc.2008.05.007 · DOI
  28. Liebregts, 2016, Effect of alcohol dosage on long-term outcomes after alcohol ablation in patients with hypertrophic cardiomyopathy, Catheter Cardiovasc Interv, 88, 945, 10.1002/ccd.26448 · DOI
  29. Veselka, 2011, Long-term effects of varying alcohol dosing in percutaneous septal ablation for obstructive hypertrophic cardiomyopathy: a randomised study with a follow up to 11 years, Can J Cardiol, 27, 763, 10.1016/j.cjca.2011.09.001 · DOI
  30. Faber, 1998, Percutaneous transluminal septal myocardial ablation in hypertrophic cardiomyopathy: results with respect to intraprocedural myocardial contrast echocardiography, Circulation, 98, 2415, 10.1161/01.CIR.98.22.2415 · DOI
  31. Nagueh, 1998, Role of myocardial contrast echocardiography during nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy, J Am Coll Cardiol, 32, 225, 10.1016/S0735-1097(98)00220-4 · DOI
  32. Flores-Ramirez, 2001, Echocardiographic insights into the mechanisms of relief of left ventricular outflow tract obstruction after nonsurgical septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy, J Am Coll Cardiol, 37, 208, 10.1016/S0735-1097(00)01045-7 · DOI
  33. Faber, 2004, Echo-guided percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: 7 years of experience, Eur J Echocardiogr, 5, 347, 10.1016/j.euje.2004.01.001 · DOI
  34. Moya Mur, 2014, Three-dimensional contrast echocardiography-guided alcohol septal ablation in hypertrophic obstructive cardiomyopathy, Eur Heart J Cardiovasc Imaging, 15, 226, 10.1093/ehjci/jet152 · DOI
  35. Schäfer, 2015, Targeting systolic anterior motion and left ventricular outflow tract obstruction in hypertrophic obstructed cardiomyopathy with a MitraClip, EuroIntervention, 11, 942, 10.4244/EIJY14M08_13 · DOI
  36. Sorajja, 2016, First experience with percutaneous mitral valve plication as primary therapy for symptomatic obstructive hypertrophic cardiomyopathy, J Am Coll Cardiol, 67, 2811, 10.1016/j.jacc.2016.03.587 · DOI
  37. Nagueh, 2011, Alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy: a multicenter North American Registry, J Am Coll Cardiol, 58, 2322, 10.1016/j.jacc.2011.06.073 · DOI
  38. Mohr, 1998, The outcome of surgical treatment of hypertrophic obstructive cardiomyopathy: experience over 15 years, J Thorac Cardiovasc Surg, 97, 666, 10.1016/S0022-5223(19)34512-X · DOI
  39. Veselka, 2016, Long-term clinical outcome after alcohol septal ablation for obstructive hypertrophic cardiomyopathy: results from the Euro-ASA registry, Eur Heart J, 37, 1517, 10.1093/eurheartj/ehv693 · DOI · Paper page
  40. Schaff, 2012, Expanding the indication for septal myectomy in patients with hypertrophic cardiomyopathy: results of operation in patients with latent obstruction, J Thorac Cardiovasc Surg, 143, 303, 10.1016/j.jtcvs.2011.10.059 · DOI

Cited by

Sorted by citations

Metadata

Authors
Liebregts, M., Vriesendorp, P. A., & ten Berg, J. M.
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2017-07
Volume
70
Issue
4
Pages
481-488
ISSN
0735-1097
DOI
10.1016/j.jacc.2017.02.080
Cited by
40
References
0
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review